Profile
TAK ZTS HLN TEVA NBIX VTRS
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc. Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $43.45B $82.06B $42.15B $19.37B $14.77B $14.38B
Employees 49.28K 14.10K 25.41K 35.00K 1.45K 33.00K
CEO Mr. Christophe Weber Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Richard D. Francis Dr. Kevin C. Gorman Ph.D. Mr. Scott Andrew Smith
Ratings
TAK ZTS HLN TEVA NBIX VTRS
Quant Rating Score 2 3 3 1 3 3
Quant Rating Sell Neutral Neutral Strong Sell Neutral Neutral
Trading
TAK ZTS HLN TEVA NBIX VTRS
Last Close $13.77 $179.84 $9.23 $17.1 $146.8 $12.08
High 52 $16.32 $200.09 $9.23 $17.4 $147.46 $13.53
Low 52 $12.6 $145.54 $7.78 $8.12 $101.19 $8.77
Price vs. 52 Week High -15.63 % -10.12 % 0 % -1.72 % -0.45 % -10.72 %
Price vs. 52 Week Low 9.29 % 23.57 % 18.64 % 110.59 % 45.07 % 37.74 %
Total Return
TAK ZTS HLN TEVA NBIX VTRS
1 Month Return 6.66 % 1.92 % 9.49 % 5.17 % 9.3 % 15.27 %
3 Month Return 5.68 % 13.52 % 9.23 % 23.82 % 7.95 % 4.41 %
6 Month Return -5.68 % -6.1 % 12.97 % 43.58 % 3.27 % 1.26 %
9 Month Return 2.27 % 15.26 % 18.49 % 110.59 % 38.4 % 37.74 %
YTD Return -3.5 % -8.88 % 12.15 % 63.79 % 11.41 % 11.54 %
1 Year Return -11.79 % -4.69 % 6.28 % 103.09 % 44.99 % 16.94 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA NBIX VTRS
Dividend Yield Percentage (TTM) 4.08 % 0.93 % 2.12 % - - 3.97 %
Dividend Paid and Capex Coverage Ration (TTM) 0.92 % 1.76 % - 3.3 % 20.82 % 2.4 %
Dividend Per Share (TTM) 0.56 % 1.67 % 0.15 % - - 0.48 %
Payout Ratio (TTM) 199.34 % 29.95 % - - - -1024.24 %
Growth
TAK ZTS HLN TEVA NBIX VTRS
Asset Growth 8.25 % -4.28 % -2.18 % -1.2 % 37.27 % -4.67 %
Gross Profit Growth -16.6 % 3.7 % 5.85 % 9.64 % 26.06 % 1.09 %
Revenue Growth 5.87 % 5.74 % 4.09 % 6.16 % 26.76 % -5.42 %
Revenue 3 Year 33.13 % 31.98 % 13.9 % -6.92 % 71.93 % -35.51 %
Revenue 5 Year 149.89 % 53.64 % 32.87 % -23.33 % 308.36 % -42.34 %
Revenue 10 Year 154.38 % 103.1 % 32.87 % -40.82 % 44100.16 % -28.91 %
EBIT Growth 7.34 % 6.27 % 37.26 % -84.52 % 0.76 % 390.23 %
Net Income Growth -54.56 % 10.88 % -1.04 % 76.24 % 61.62 % -97.37 %
Net Income 3 Yeari Growth Per Share -61.74 % 47.55 % -8.67 % 86.29 % -41.58 % 104.09 %
Net Income 5 Yeari Growth Per Share 62.27 % 71.94 % 59.66 % 76.28 % 1054.95 % -93.35 %
Net Income 10 Yeari Growth Per Share 36.33 % 404.24 % 59.66 % -133.42 % 470.4 % -97.2 %
Operating Income Growth 7.34 % 6.27 % 37.26 % -84.52 % 0.76 % 390.23 %
Operating Cash Flow Growth (CFG) -34.47 % 23.06 % -16.48 % -13.96 % 14.88 % -5.18 %
Operating 3 Year CFG -36.76 % 14.12 % 22.08 % 10.09 % 62.6 % 13.84 %
Operating 5 Year CFG 139.61 % 37.69 % 118.54 % -48.98 % 275.6 % -48.75 %
Operating 10 Year CFG 335.67 % 274.61 % 118.54 % -67.94 % 1000.37 % -19.21 %
EPS Growth -54.92 % 12.64 % - 76.42 % 59.01 % -97.33 %
EPS Diluted Growth -54.86 % 12.92 % - 76.42 % 58.33 % -97.35 %
Book Value Per Share 13.54 % 15.34 % 1.38 % -5.72 % 28.15 % -1.92 %
Share Holder 3 Year Equity Growth Per Share 40.38 % 36.7 % -36.6 % -26.74 % 88.86 % -55.34 %
Share Holder 5 Year Equity Growth Per Share 73.27 % 139.55 % -39.41 % -53.44 % 353.33 % -27.89 %
Share Holder 10 Year Equity Growth Per Share 197.1 % 476.36 % -39.41 % -74.76 % 1167.34 % 122.18 %
Dividend Per Share Growth 1.95 % 15.15 % -85.58 % - - -0.06 %
Dividend 3 Year Growth Per Share 1.19 % 87.76 % -83.69 % - - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % -100 % - -
Dividend 10 Year Growth Per Share 103.93 % 665.58 % -66.42 % -100 % - -
Debt Growth 24.67 % -15.91 % -9.43 % -6.53 % 62.95 % -4.64 %
Free Cash Flow Growth -53.54 % 22.25 % -20.06 % -19.19 % 11.99 % -7.35 %
Updated On 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
TAK ZTS HLN TEVA NBIX VTRS
Gross Profit Margin TTM 66.54 % 69.2 % 60.04 % 48.99 % 97.78 % 41.92 %
Return on Assets TTM 0.95 % 16.66 % - -1.15 % 10.65 % -0.12 %
Return on Equity TTM 2.06 % 48.41 % 6.53 % -6.86 % 17.45 % -0.27 %
Return on Capital Employed TTM 3.22 % 25.86 % - 3.75 % 17.05 % 4.44 %
Net Income Per EBT TTM 293.72 % 80.07 % 64.62 % 59.18 % 78.68 % -66.16 %
EBT Per Ebit TTM 11.92 % 92.82 % 82.52 % -76.63 % 99.89 % 4.83 %
EBIT Per Revenue TTM 9.65 % 36.83 % 18.08 % 6.79 % 23.73 % 11.45 %
Cash Flow To Debt Ratio TTM 14.47 % 36.43 % - 8.57 % 118.01 % 13.53 %
Receivables Turnover TTM 6.11 6.75 - 4.63 4.4 3.89
Payables Turnover TTM 4.46 6.64 - 3.35 0.5 5.63
Inventory Turnover TTM 1.18 1.01 - 2.07 1.18 2.33
Fixed Asset Turnover TTM 214.28 % 251.27 % - 267.75 % 572.67 % 520.01 %
Asset Turnover TTM 28.22 % 60.87 % - 37.45 % 57.08 % 32.41 %
Operating Cash Flow Per Share TTM 452.66 5.24 - 1.5 6.47 2.04
Free Cash Flow Per Share TTM 146.27 3.82 - 1.04 6.16 1.67
Cash Per Share TTM 29177.57 % 431.22 % 22.71 % 266.34 % 1213.03 % 92.6 %
Operating Cash Flow Sales Ratio TTM 16.66 % 27.47 % - 10.51 % 32.56 % 15.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 32.31 % 72.95 % - 69.66 % 95.2 % 81.87 %
Cash Flow Coverage Ratios TTM 14.47 % 36.43 % - 8.57 % 118.01 % 13.53 %
Price To Free Cash Flows Ratio TTM 29.1 46.89 - 16.51 24.05 7.19
Price To Operating Cash Flows Ratio TTM 4.68 34.33 - 11.4 22.7 5.91
Price Cash Flow Ratio TTM 4.68 34.33 - 11.4 22.7 5.91
Income Statement (TTM)
TAK ZTS HLN TEVA NBIX VTRS
Revenue $4263.76B $8.54B $11.3B $15.85B $1.89B $15.38B
Gross Profit $2321.31B $5.83B $6.96B $7.65B $1.85B $6.57B
Gross Profit Ratio 54.44% 68.28% 61.6% 48.25% 97.9% 42.7%
EBITDA $1254.52B $3.56B $2.81B $4.27B $0.42B $4.73B
Net Income $144.07B $2.34B $1.05B $-0.56B $0.25B $0.05B
EPS Diluted 91.16 5.07 0.11 -0.5 2.47 0.05
Balance Sheet (MRQ)
TAK ZTS HLN TEVA NBIX VTRS
Long Term Debt $4476.5B $6.56B $8.8B $18.48B $0.26B $16.19B
Total Liabilities $7834.79B $9.3B $17.33B $35.35B $1.02B $27.22B
Total Equity $7274.01B $4.99B $16.73B $8.13B $2.23B $20.47B
Total Investments $683.22B $0.02B $0.07B $0.01B $0.94B $1.23B
Total Debt $5463.39B $6.8B $9.46B $20.15B $0.43B $18.38B
Total Assets $15108.79B $14.29B $34.06B $43.48B $3.25B $47.69B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA NBIX VTRS
Net Income $144.07B $2.34B $1.05B $-0.62B $0.25B $0.05B
Inventory $-115.74B $-0.36B $-0.13B $-0.15B $0.01B $-0.61B
Dividends Paid $-287.19B $-0.69B $-0.39B $0B $0B $-0.58B
Operating Cash Flow $640.32B $2.35B $1.72B $1.37B $0.39B $2.8B
Capital Expenditure $-480.73B $-0.73B $-0.34B $-0.53B $-0.03B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.9
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.45
AKAN Akanda Corp. 1.63
ALIM Alimera Sciences, Inc. 5.57
ALVO Alvotech 11.59
ALVOW Alvotech 2.59
AMPH Amphastar Pharmaceuticals, Inc. 42.48
AMRX Amneal Pharmaceuticals, Inc. 7.44
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 63.25
AQST Aquestive Therapeutics, Inc. 3.82
ASRT Assertio Holdings, Inc. 1.505
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 16.72
AYTU Aytu BioPharma, Inc. 2.7
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0 59.35
CVY Invesco Zacks Multi-Asset Income ETF 0.646 26.2246
GCOW Pacer Global Cash Cows Dividend ETF 0.74 35.15
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 43.37
FPXI First Trust International Equity Opportunities ETF 2.11 46.48
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 30.92
PPH VanEck Pharmaceutical ETF 0 93.28
VETS Pacer Military Times Best Employers ETF 0.25 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 33.28
PTIN Pacer Trendpilot International ETF 0.25 29.2454
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.25 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.25 32
AVDE Avantis International Equity ETF 0.09 63.62
GERM ETFMG Treatments, Testing and Advancements ETF 0.84 19.8874
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.08 56.9899
DFIC Dimensional International Core Equity 2 ETF 0.00149316 26.83
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 36.9
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00102933 25.68
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.25 41.14
Unlock